| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:45 | Catalyst's New CEO Has Big Ideas For The Small Biotech | 1 | Investor's Business Daily | ||
| 14:46 | Curia Global, Inc.: Curia und Carterra kooperieren bei Biologika-Symposium zur Förderung der Biotechnologieforschung im pazifischen Nordwesten | 142 | GlobeNewswire (Deutschland) | ALBANY, New York und SALT LAKE CITY, May 10, 2024 (GLOBE NEWSWIRE) -- Curia, ein führendes Auftragsforschungsinstitut sowie Entwicklungs- und Produktionsunternehmen, und Carterra Inc., der Weltmarktführer... ► Artikel lesen | |
| 14:27 | IN BRIEF: NetScientific says PDS Biotech's Versamune meets endpoints | 1 | Alliance News | ||
| 14:15 | Biotech Rockets 125% On Sanofi Covid Vaccine Agreement | 3 | Investor's Business Daily | ||
| 13:45 | Will the Biotech Sector Shift From Lagger to Leader? | 1 | MarketBeat | ||
| 13:01 | 3 Biotech Stocks to Sell in May Before They Crash & Burn | 1 | InvestorPlace | ||
| 12:05 | NOVAVAX - Biotech-Aktie explodiert! Kooperation mit Sanofi! | 24 | stock3.com | ||
| 10:12 | NetScientific PLC - PDS Biotech: Clinical trial meets study endpoints | 1 | RNS | ||
| 09:42 | CHA Bio, Boston's CIC to establish open innovation center for biotech ventures | 1 | Korea Joongang Daily | ||
| 08:50 | Up close and personal with ASX tech and Biotech | 1 | Stockhead | ||
| 01:10 | Adverum Biotechnologies Inc reports results for the quarter ended in March - Earnings Summary | 1 | Reuters | ||
| Do | PDS Biotechnology Corporation: PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer | 15 | GlobeNewswire (Europe) | 30 month median overall survival (OS); median OS independent of patient CPS score ORR 34% (CPS=1); 48% (CPS=20) Phase 3 registrational trial planned to initiate in 2024 PRINCETON, N.J., May 09, 2024... ► Artikel lesen | |
| Do | Top ASX biotechs catching the eye of analysts and fund managers in 2024 - Part 2 | 1 | Stockhead | ||
| Do | Oncolytics Biotech GAAP EPS of -$0.09 misses by $0.01 | 1 | Seeking Alpha | ||
| Do | Adverum Biotechnologies, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Do | Adverum Biotechnologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Do | Oncolytics Biotech Inc.: Oncolytics Biotech Reports First Quarter 2024 Financial Results and Operational Highlights | 44 | PR Newswire | Pelareorep advancing to registration-enabling studies
Preparations underway for Type C meeting with the FDA to establish registrational pathway in HR+/HER2- metastatic breast cancer
Overall survival... ► Artikel lesen | |
| Do | 2 Biotech Stocks to Watch Under $20 | - | Schaeffer's Research | ||
| Do | Oncolytics Biotech approved to expand pancreatic cancer program | 3 | The Market Herald Canada | ||
| Do | LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.383 |
| MERCEDES-BENZ | 2.204 |
| PLUG POWER | 2.169 |
| BAYER | 1.936 |
| NEL | 1.704 |
| TUI | 1.627 |
| SIEMENS ENERGY | 1.494 |
| ALLIANZ | 1.480 |
| BYD | 1.151 |
| PALANTIR TECHNOLOGIES | 1.096 |
| NVIDIA | 1.074 |
| RWE | 1.001 |
| DEUTSCHE BANK | 998 |
| DEUTSCHE LUFTHANSA | 872 |
| VOLKSWAGEN | 790 |
| RHEINMETALL | 783 |
| RENK GROUP | 762 |
| NORDEX | 740 |
| BASF | 731 |
| INFINEON | 717 |
| TESLA | 704 |
| NOVAVAX | 700 |
| COMMERZBANK | 696 |
| AIXTRON SE | 686 |
| SUPER MICRO COMPUTER | 680 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
